IL6 and neoplasm: Elevated systemic inflammation is driven by chronic release of proinflammatory cytokines (e.g., IL-6, TNF-α), recruitment of neutrophils and macrophages, and expansion of Th1/Th17 responses—features linked to tumor progression and immune dysregulation in colon cancer [42,43].